Sartorius AG Stock Borsa Italiana
Stocks
1SRT3
DE0007165631
Advanced Medical Equipment & Technology
OTC Markets Traded|
Real-time Estimate
Tradegate
22:59:20 12/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 252.85 EUR | +0.14% |
|
0.00% | +5.38% |
| 07:44pm | Sartorius AG : JP Morgan maintains a Buy rating | ZD |
| 10-08 | AlphaValue's positive view is not enough for Sartorius Stedim Biotech |  |
| Market Cap | 15.81B 17.66B 14.74B 13.37B 25.21B 1,688B 25.37B 177B 69.32B 871B 66.33B 64.86B 2,803B | P/E 2026 * |
68.2x | P/E 2027 * | 52.4x |
|---|---|---|---|---|---|
| Enterprise Value | 19.39B 21.66B 18.07B 16.39B 30.92B 2,070B 31.11B 217B 85.02B 1,068B 81.35B 79.54B 3,438B | EV / Sales 2026 * |
5.22x | EV / Sales 2027 * | 4.68x |
| Free-Float |
35.87% | Yield 2026 * |
0.31% | Yield 2027 * | 0.38% |
| Markets | Quality | ||
|---|---|---|---|
Xetra
| SRT3 | Delayed | |
CBOE
| SRT3d | Real-time | |
|
Tradegate
| SRT3 | Real-time | |
|
Börse Stuttgart
| SRT3 | Delayed | |
|
Boerse Muenchen
| SRT3 | Real-time | |
|
Deutsche Boerse AG
| SRT3 | Delayed | |
|
OTC Markets
| SUVPF | Delayed | |
|
London S.E.
| 0NIR | Delayed | |
|
CBOE
| 0NIR | Real-time | |
|
Swiss Exchange
| SRT3 | Delayed | |
|
Wiener Boerse
| SRT3 | End-of-day quote | |
|
Borsa Italiana
| 1SRT3 | End-of-day quote |
Last Transcript: Sartorius AG
| 1 day | +0.14% | ||
| Current month | -1.79% | ||
| 1 month | +7.95% | ||
| 3 months | +3.91% | ||
| 6 months | +17.06% | ||
| Current year | +5.38% |
| 1 month | 228.1 |  | 264 |
| Current year | 203.8 | | 264.6 |
| 1 year | 203.8 | | 264.6 |
| 3 years | 176.85 | | 381.4 |
| 5 years | 176.85 | | 612.2 |
| 10 years | 172.3 | | 612.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Grosse
CEO | Chief Executive Officer | 59 | 30/06/2025 |
Florian Funck
DFI | Director of Finance/CFO | 55 | 01/04/2024 |
Volker Niebel
COO | Chief Operating Officer | 70 | 01/01/2001 |
| Director | Title | Age | Since |
|---|---|---|---|
Annette Becker
BRD | Director/Board Member | 62 | 01/09/2002 |
Lothar Kappich
CHM | Chairman | 69 | 19/07/2017 |
| Director/Board Member | 77 | 29/11/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.14% | 0.00% | - | - | 17.7B | |
| +0.56% | -2.58% | +25.68% | +36.63% | 243B | |
| +0.66% | -0.20% | +7.62% | +5.39% | 155B | |
| +0.10% | +5.21% | -1.85% | +60.70% | 150B | |
| +1.01% | +3.00% | -54.01% | -10.22% | 61.93B | |
| +1.38% | -1.19% | +18.15% | +23.27% | 49.12B | |
| +1.25% | +5.82% | -16.25% | -17.42% | 48.78B | |
| +0.49% | -0.29% | +23.55% | +56.77% | 48.08B | |
| -0.38% | +4.02% | +3.06% | +36.52% | 47.95B | |
| -0.43% | -2.07% | +28.15% | +71.72% | 42.62B | |
| Average | +0.34% | +3.01% | +3.79% | +29.26% | 94.01B | |
| Weighted average by Cap. | +0.40% | +2.97% | +7.54% | +30.77% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.71B 4.15B 3.46B 3.14B 5.92B 396B 5.96B 41.57B 16.27B 204B 15.57B 15.23B 658B | 4.08B 4.56B 3.8B 3.45B 6.51B 436B 6.55B 45.7B 17.89B 225B 17.12B 16.74B 723B |
| Net income | 248M 277M 231M 210M 396M 26.52B 399M 2.78B 1.09B 13.68B 1.04B 1.02B 44.04B | 318M 355M 296M 269M 507M 33.94B 510M 3.56B 1.39B 17.51B 1.33B 1.3B 56.36B |
| Net Debt | 3.58B 4B 3.34B 3.03B 5.71B 382B 5.74B 40.1B 15.7B 197B 15.02B 14.69B 635B | 3.29B 3.67B 3.06B 2.78B 5.24B 351B 5.28B 36.83B 14.42B 181B 13.8B 13.49B 583B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | €252.50 | +1.00% | 0 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SRT3 Stock
- 1SRT3 Stock
Select your edition
All financial news and data tailored to specific country editions
